DPP4 and diabetes mellitus: Dipeptidyl-peptidase IV inhibitors (DPP-4i) are widely prescribed for the treatment of type 2 diabetes mellitus (T2DM) because of their several advantages; they effectively control blood sugar, pose a low risk of hypoglycemia, and are neutral for weight [1].